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Rapid respiratory failure due to invasive mycosis of the airways is an uncommon presentation of Aspergillus infection, even in
immunocompromised patients, and very few pediatric cases have been reported. Patients withAspergillus tracheobronchitis present
with nonspecific symptoms, and radiologic studies are often noninformative, leading to a delay in diagnosis. Prompt initiation of
adequate antifungal therapies is of utmost importance to improve outcome. We report the case of a 9-year-old girl with chronic
myelogenous leukemia who developed respiratory distress 41 days after hematopoietic cell transplantation and rapidly deteriorated
despite multiple interventions and treatment modalities.
1. Introduction
Aspergillus tracheobronchitis (AT) is a rare but severe form
of invasive pulmonary aspergillosis. AT is associated with
very high mortality, especially in neutropenic patients (90%)
[1], highly immunocompromised patients with hematologic
malignancies, and patients undergoing hematopoietic cell
transplantation (70%, reviewed in [2]). Patients generally
present with nonspecific symptoms, such as cough, fever,
and respiratory distress, and radiologic studies are often
noninformative, in as many as 47% according to a recent
review [1], which may lead to a delay in diagnosis.
Prompt initiation of adequate antifungal therapies is of
utmost importance to improve outcome. Surgical removal
of infected tissue and adjunctive therapies to help relieve
airway obstruction should be considered early to improve
survival rates. Direct bronchoscopy with visualization of the
airways is the gold standard for diagnosis and is important
for obtaining tissue for microscopic analysis and culture.
However, this is often not performed without hesitation, as it
is an invasive procedure and carries risks, such as potentially
fatal hemorrhage [3].
Over 150 cases of AT have been described in the literature
over the last few decades, but only very few pediatric patients
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have been reported to date [4, 5]. Thus we describe the
case of a 9-year-old girl with chronic myelogenous leukemia
status after hematopoietic cell transplantation (HCT) who
developed severe pseudomembranous and obstructive AT,
respiratory failure, and subsequent death despite multiple
aggressive interventions.
2. Case Report
The patient was a 9-year-old girl with chronic myeloge-
nous leukemia that presented in blast crisis who under-
went 5/6 HLA-mismatched unrelated umbilical cord blood
transplant following conditioning with total body irradia-
tion, cyclophosphamide, and antithymocyte globulin. She
had achieved cytogenetic and molecular remission prior to
transplant, and neutrophil engraftment occurred on day 30.
Before transplant, she had suffered two episodes of coagulase-
negative staphylococcal bacteremia, but after the transplant
she had an initially uncomplicated course without infectious
issues. She received antibiotic prophylaxis with ampicillin-
sulbactam empirically after transplant and cyclosporine and
prednisone for graft versus host disease (GVH) prophylaxis.
Two days prior to symptom development, the patient under-
went elective percutaneous endoscopic gastrostomy tube
placement. Thirty-nine days after transplant, she developed
low-grade fevers, a sore throat, rhinorrhea, a nonproductive
cough, and a purple-colored macular rash. Blood, urine,
and nasopharyngeal samples were sent for cultures and viral
testing, which remained negative, and empiric antibiotic
coverage was broadened. Of note, surveillance cultures from
the patient’s nares and throat were sent on admission and
weekly thereafter, which all remained negative. Rectal swab
surveillance revealed vancomycin-resistant Enterococcus fae-
cium.
Two days later, she developed mild respiratory distress
with diffuse scattered wheezing bilaterally on exam. A
CXR was unchanged and normal. With worsening respira-
tory course, antimicrobial therapy included IV clindamycin
(12mg/kg every eight hours), vancomycin (20mg/kg every
6 hours), meropenem (20mg/kg every 8 hours), ambisome
(3mg/kg daily with planned increase to 5mg/kg when fungal
elements were seen), azithromycin 5mg/kg daily, and with
further progression a single dose of cidofovir (5mg/kg).
With fungal elements obtained from tracheal tissue and with
progressive Aspergillus infection in the differential diagnosis,
posaconazole was added (enteral with formula at approxi-
mately 5-6mg/kg given 4 times daily). The following day,
she developed stridor and supra- and substernal retractions.
A repeat CXR was again unchanged, but lateral neck films
showed subglottic airway narrowing with soft tissue fullness
of the glottis and subglottic areas. She was transferred to
the pediatric intensive care unit for increasing respiratory
distress. Noninvasive positive pressure ventilation in the
form of BIPAP caused neither relief of her symptoms nor
improvement of aeration. She was brought to the operating
room for direct laryngoscopy and tracheobronchoscopy,
which revealed an erythematous and edematous supraglottis
and extensive pseudomembranous and obstructive tracheitis.
An estimated 50–60% of the entire tracheal lumen was filled
Figure 1: View of the trachea during bronchoscopy. Note the
obstruction of >50% of the tracheal lumen by whitish thick secre-
tions.
Figure 2: View of the carina during bronchoscopy. Note the thick,
pseudomembranous white material obstructing a great portion of
bothmainstem bronchi and the optical foreign body forceps in place
used to gently remove these.
with thick, whitish secretions, in addition to a mucosal
pseudomembrane that was visualized down to the carina
(Figure 1). After mechanical removal of the secretions and
pseudomembranes (Figure 2), she was left intubated and
readmitted to the intensive care unit for further care.
Over the next few hours, she developed worsening bipha-
sic airway obstruction.
She was increasingly difficult to ventilate despite sev-
eral different attempted modes of ventilation and muscle
relaxation. Treatment adjuncts included heliox (a mixture of
helium and oxygen), to decrease airway turbulence, inhaled
albuterol, intravenous terbutaline, and ketamine infusions for
bronchodilation.
A repeat airway evaluation the following day revealed
near-obstructive tenacious material adherent to the mucosa
of the entire trachea. Thick mucoid secretions obscured
all visible bronchi. Again, operative debridement of the
pseudomembranes was attempted as distally as possible,
but without significant improvement in her status. Trials of
nebulized dornase alfa, bicarbonate, and acetylcysteine did
not ameliorate the airway obstruction.
Microscopic examination of the debris obtained by bron-
choalveolar lavage confirmed fungal elements consistent
with Aspergillus fumigatus (Figure 3). Sputum and airway
tissue cultures eventually grew Aspergillus fumigatus 5 days
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Figure 3: Grocott’s methenamine silver stain of a piece of pseudom-
embrane obtained during bronchoalveolar lavage showed dichoto-
mously branched and septate hyphae, suggestive of the diagnosis of
Aspergillus. 400-fold magnification.
Figure 4: Autopsy: posterior view of left bronchial tree demon-
strating the complete filling of even most distal airways with yellow
gelatinous material.
postmortem as well. Systemic antifungal therapy was broad-
ened to include nebulized amphotericin B (2.5mg/hour) and
enteral posaconazole (200mg PG q6h 5-6mg/kg 4 times
daily).
In discussion with the patient’s family, given their daugh-
ter’s poor prognosis, the decision was made to withdraw
life-supporting treatments. Mechanical ventilation was dis-
continued, comfort ensured with titration of opioids and
benzodiazepines, and the patient passed away in the presence
of her family.
Postmortem examination revealed tan-yellow, tenacious
patchy tracheal membranes. The entire bronchial tree was
lined with tan-yellow material and all lumen were narrowed
or obstructed at the level of the small intrasegmental bronchi
(Figures 4 and 5). There was peribronchial congestion and
hemorrhage (Figure 6), as well as hilar and mediastinal
lymphadenopathy. Autopsy cultures confirmed Aspergillus
fumigatus.
3. Discussion
This case demonstrates an acute presentation of Aspergillus
tracheobronchitis in a 9-year-old girl after HCTwith nonspe-
cific respiratory symptoms initially, including a nonproduc-
tive cough and sore throat, followed by scatteredwheezes, and
Figure 5: Autopsy: coronal cut through lung demonstrating peri-
bronchial congestion and hemorrhage.
Figure 6: Histopathology: 10-fold magnification and H+E stain of a
large bronchus demonstrating an entirely obstructed lumen.
subsequently mild stridor. After this three-day prodrome,
the patient developed rapidly progressive respiratory failure
requiring multiple interventions without success in treating
her infection and airway obstruction.
Although invasive aspergillosis is an uncommon diag-
nosis, immunosuppressed patients who present with fever
and nonspecific respiratory symptoms, including airway
obstruction and bronchospasm or even unilateral wheezing
[6], should be evaluated for Aspergillus tracheitis promptly,
ideally by bronchoscopy [2, 7]. Bronchoscopy has been
reported to be a risky procedure in patients with invasive
pulmonary aspergillosis, as Aspergillus invades tissue and
removal of infected material can lead to massive hemorrhage
[3]. However, bronchoscopy has recently been reported to be
a safe procedure in children with leukemia and respiratory
symptoms, where complications seemed rare and transient,
but it should be noted that only 3 of the 31 patients in this
report were infected withAspergillus [8]. Bronchoscopy is the
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only method available for endobronchial disease assessment,
and it also enables tracheal and bronchial tissue sampling for
microscopic analysis and culture, allowing early diagnosis [2,
9]. Patients with AT present with nonspecific signs and symp-
toms and have radiographic studies that are often normal or
without characteristic changes, requiring bronchoscopy for
diagnosis [1, 2, 7, 10–12].
Several classifications of AT have been proposed based on
bronchoscopic andmicroscopic appearances [13, 14], and it is
likely that different forms represent a progressive spectrum
of fungal invasion or that different forms of AT may coexist
in the same patient [2]. In order to allow prediction of the
clinical course and prognostication, a clinical classification
as suggested by Krenke and Grabczak seems to be useful
for clinicians [2]. Our patient fell into the second category
of “highly immunocompromised patients with hematologic
malignancies and/or patients undergoing hematopoietic cell
transplantation,” which is described as having amuch poorer
outcome than lung transplant patients or in other groups of
patients suffering from AT [2]. This is supported by several
reports of patients with a combination of having undergone
HCT with the diagnosis of Aspergillus tracheobronchitis who
almost always had a fatal outcome [6, 12, 15–19]. The need
for mechanical ventilation in immunosuppressed patients
with AT also suggests a poor prognosis [7]. In pediatric
patients with invasive aspergillosis, having undergone HCT
led to a sixfold higher risk of death and the only predictor of
improved survival was surgical intervention [20]. Survival of
AT is possible if diagnosis is made promptly and provided the
patient can tolerate removal of the infected material [5, 15, 16,
18, 21].
Overall, only very few cases of children with AT have
been reported in the literature and therefore it is difficult
to determine the prognosis of children affected by AT. Two
recent case reports, with survival of a 5-year-old girl with
Fanconi anemia with neutropenia [5] and a 6-year-old girl
with acute lymphocytic leukemia after HCT with localized
AT [4], are promising.
In our case, once the diagnosis of pseudomembranous
and obstructive AT was made, management in the pedi-
atric intensive care unit focused on deliberate ventilatory
maneuvers, bronchodilation, minimizing airway turbulence,
and dissolving the mechanical obstruction with nebulized
acetylcysteine and amphotericin B in addition to mechanical
removal of obstructive material. Our patient had already
been treated with systemic antifungals for several days,
broadened by addition of a second antifungal agent. Unfor-
tunately, the infection had progressed too far to allow for her
recovery.
In conclusion, the diagnosis of AT should be considered
and bronchoscopy should be undertaken early in immuno-
suppressed pediatric patients with nonspecific respiratory
symptoms and normal radiographic studies, to allow prompt
diagnosis. Early diagnosis can enable timely initiation of
therapy, including adequate systemic and local antifungal
coverage, in addition to adjuvant local therapies and thor-
ough removal of infectious material. Once respiratory failure
occurs, the prognosis of AT remains poor.
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